Athersys, Inc. (NASDAQ:ATHX) has earned an average broker rating score of 1.00 (Strong Buy) from the three analysts that provide coverage for the company, Zacks Investment Research reports. Three equities research …
BNS3d
Target Corporation
"(ATHX) Given a $9.00 Price Target by Maxim Group Analysts" was first reported by Chaffey Breeze and is the sole property of of Chaffey Breeze. State Street Corp now owns 1,119,590 shares of the biopharmaceutical …
Analyst
Athersys (NASDAQ:ATHX) is a Cleveland, Ohio based emerging biotechnology company in the field of regenerative medicine. (Athersys, common stock price chart. Source: Bloomberg) Technology: The company …
cell therapy
Athersys is having an incredibly strong day in the market today. After starting the day off in the red, the stock started moving upward as soon as the opening bell rang. Since then, we've seen a continuation of strong …
Presentation
Shares of Athersys, Inc. (ATHX - Free Report) surged significantly in the post market trading on Mar 28 after research firm William Blair initiated a coverage on the stock with an outperform rating. Share Price Movement …
Athersys, Inc. (NASDAQ:ATHX)‘s stock had its “outperform” rating restated by equities researchers at William Blair in a note issued to investors on Tuesday. Other research analysts also recently issued reports about the …
The stock, after opening at $0.34 ... Analyst's mean target price for …
NASDAQ
Investors in Athersys, Inc. ATHX need to pay close attention to the stock based on moves in the options market lately. That is because the April 21st, 2017 $1 Call had some of the highest implied volatility ...
Athersys (ATHX): ATHX stock is up 9.84% today ... Article printed from InvestorPlace Media, http://investorplace.com/2016/03/biggest-movers-in-manufacturing-stocks-now-fprx-ktos-athx-petx/.